Skip to main content

Table 1 Baseline characteristics of the patients with TAK and HCs

From: Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis

 

TAK (n = 76)

HCs (n = 56)

P value

Age, years (IQR)

51 (31–68)

48 (34–63)

0.2333

Female, n, %

67, 88.2

48, 85.7

0.794

Body mass index, kg/m2 (IQR)

22.0 (20.1–24.7)

21.2 (19.2–23.5)

0.2436

Rheumatic disease

   

 Rheumatoid arthritis, n, %

4, 5.3

0

0.1366

 Sjögren’s syndrome, n, %

1, 1.3

0

 > 0.9999

Smoking (current or past) n, %

18, 23.7

11, 19.6

0.6726

Medication

   

 Anti-hypertension drug, n, %

36, 47.4

6, 10.7

 < 0.0001

 Statin, n, %

33, 43.4

5, 8.9

 < 0.0001

 Metformin, n, %

1, 1.3

2, 3.6

0.574

 Proton pump inhibitor, n, %

55, 72.4

0

 < 0.0001

 Antibiotics, n, %

21, 27.6

0

 < 0.0001

  1. HCs healthy controls, IQR interquartile range, TAK Takayasu arteritis